GENWORTH FINANCIAL, INC.

Lobbying client · District of Columbia · filed 2025 to 2026

Mortgage Insurance Provider

$180,000 Reported spend

6 Filings counted

1 Firms hired

5 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (169734), not by name.

Firms hired 1

CGCN GROUP, LLC $180,000 6 filings

Bills named in these filings 5

HR 1319
American Rescue Plan Act of 2021

5 filings
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

5 filings
HR 2760
Middle Class Mortgage Insurance Premium Act of 2025

5 filings
HR 6800
To amend the Internal Revenue Code of 1986 to terminate the tax-exempt status of terrorist supporting organiz…

5 filings
HR 748
RELIEVE Act

5 filings

Reported by year 2 years

2026 $60,000 2 filings
2025 $120,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 6
SENATE 6
Natl Economic Council (NEC) 3

Recent filings 6 total

Q2

CGCN GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $30,000 income · posted Jul 19, 2026

View → Q1

CGCN GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $30,000 income · posted Apr 20, 2026

View → Q4

CGCN GROUP, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $30,000 income · posted Jan 20, 2026

View → Q3

CGCN GROUP, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $30,000 income · posted Oct 20, 2025

View → Q2

CGCN GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $30,000 income · posted Jul 21, 2025

View → Q1

CGCN GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $30,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.